Safety and efficacy profile of ozenoxacin 1% cream in pediatric patients with impetigo
Background: Ozenoxacin is a topical antibiotic approved in the United States for treatment of impetigo in adults and children age ≥2 months. This analysis evaluated the efficacy and safety of ozenoxacin in specific pediatric age groups. Methods: Data for children aged 2 months to <18 years recrui...
Saved in:
Main Authors: | Adelaide A. Hebert, MD (Author), Theodore Rosen, MD (Author), Núria Albareda López, BS (Author), Ilonka Zsolt, MD, PhD (Author), Xavier Masramon (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer,
2020-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Retrospective Analysis of the Real-World Use of Topical Antimicrobials in the Paediatric Population with Impetigo in Italy: Focus on the Role of Ozenoxacin 1% Cream
by: Elisa Barbieri, et al.
Published: (2023) -
The Use of Ozenoxacin in Pediatric Patients: Clinical Evidence, Efficacy and Safety
by: Giusy Davino, et al.
Published: (2020) -
Clinical and bacteriological efficacy of twice daily topical retapamulin ointment 1% in the management of impetigo and other uncomplicated superficial skin infections
by: Benjamin R. Bohaty, MD, et al.
Published: (2015) -
Impetigo Impetigo
by: Luciana Baptista Pereira
Published: (2012) -
Bullous impetigo masquerading as pemphigus foliaceus in an adult patient
by: Katherine Given Ligtenberg, MD, PhD, MBA, et al.
Published: (2020)